New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 11, 2013
05:36 EDTAMPEAmpio incorporates Luoxis Diagnostics, COO Josh Disbrow to be CEO if Luoxis
Ampio Pharmaceuticals announced the incorporation and initiation of operations of Luoxis Diagnostics, a subsidiary of Ampio that will initially be funded through a private placement, with Ampio maintaining approximately 80% ownership post financing. Josh Disbrow, Ampio's COO, will assume the role of CEO of Luoxis. Details about the private placement will follow in the near future.
News For AMPE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 21, 2015
15:57 EDTAMPEAmpio says Optina benefit not significant vs. placebo, Bloomberg reports
Vaughan Lennox Clift, Chief Regulatory Affairs Officer of Ampio, told Bloomberg in a phone interview that Optina's benefit is not significant versus the placebo. Optina helped a group improve from baseline, Bloomberg adds. Clift also said the FDA may allow narrow sales with a post-market study.
08:08 EDTAMPEAmpio announces positive study results on Optima
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use